Trial Profile
A study of DTP3 in multiple myeloma patients.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs KES 0001 (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 14 Sep 2016 New trial record